Align Technology FY Conference Summary Company Overview - **Company**: Align Technology (NasdaqGS:ALGN) - **Industry**: Healthcare Services and Dental Technology Key Points Product Portfolio Evolution - Introduction of the **Zero by Three product suite** aimed at providing flexibility to orthodontists with options for treatment duration and refinements [3][4] - The **three-year product** has become the top-selling product, reflecting advancements in technology and predictability [4][5] - The new product allows for **no refinements**, providing a lower-cost option while still offering the ability to purchase refinements as needed [5][6] Pricing and Revenue Model - The **average selling price (ASP)** is influenced by country growth and product mix, with lower list prices in emerging markets affecting overall ASP [12][13] - Anticipated **1%-2% decrease in ASP** due to new doctor onboarding and product mix changes, but gross margins are expected to remain strong at **75%-80%** [15][16] Market Dynamics and Demand Strategies - In the U.S., the market is described as **stable but discretionary**, with a focus on active patient engagement through visualization tools and financing options [19][20] - **Double-digit growth** in Doctor Service Organizations (DSOs) is noted, attributed to active marketing and patient engagement strategies [22][23] International Market Trends - Strong growth observed in **Eastern Europe, Middle East**, and parts of **Southeast Asia**, with ongoing efforts to expand in these regions [32][33] - The company is focusing on training and increasing the number of doctors using Invisalign in **Asia**, particularly in **Japan and China** [34][35] Direct Fabrication and Manufacturing Innovations - The company is advancing towards **direct fabrication** of aligners, which will eliminate the need for molds and allow for more customizable products [41][42] - Initial rollout of **directly fabricated retainers** is expected in 2026, with plans to scale up production for more complex aligners thereafter [46][47] Financial Outlook and Margin Improvement - Expected **100 basis points improvement** in operating margin due to product portfolio evolution and restructuring efforts [18][55] - The company aims to maintain a **CapEx** of **3%-4% of revenue** to support ongoing manufacturing needs and innovations [50][51] M&A Strategy - Align Technology remains focused on **M&A opportunities** that align with its core business of digital orthodontics, particularly in moving teeth [60][61] Future Goals - The company aims to drive **volume growth** and increase the number of doctors using its products, with a focus on maintaining stability in North America and expanding internationally [64][68] - Anticipation of **new product launches** and scaling of direct fabrication capabilities as key milestones for 2026 [65][66] Additional Insights - The potential impact of **stimulus checks** on consumer spending for orthodontic treatments is acknowledged, with historical data showing increased demand during such periods [25][26] - The company is well-positioned in China, with a focus on local manufacturing and treatment planning to navigate market dynamics effectively [39][40]